Kinneret Klein

Kinneret Klein, MBA, CPA, currently serves as Executive Director of Commercial Financial Planning & Analysis at BioCryst Pharmaceuticals, Inc., since July 2023. Previously, Kinneret held the position of Director of Commercial Financial Planning & Analysis at Kyowa Kirin, Inc.- U.S., where responsibilities included overseeing financial activities, collaborating on strategic goals, and providing insights on pricing and market access. Kinneret's extensive experience also includes roles at Agile Therapeutics and Bristol Myers Squibb, focusing on financial planning, budgeting, and market access strategy. Kinneret's educational background includes a Master's degree in Accounting from Keller Graduate School of Management, an MBA in Technology from the Technion - Israel Institute of Technology, and a Bachelor of Arts in Economics and Business Administration from The Hebrew University of Jerusalem.